NCT04518644 2023-04-28
Nilotinib, for Patients With CML-CP or CML-AP
Novartis
No longer available
Clinical Trials
4 trialsNCT00905593 2012-07-18
ENACT
Novartis
Approved for marketing
NCT00302016 2011-08-26
Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Novartis
No longer available
NCT00413270 2011-07-13
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
Novartis
No longer available